Sugi Predict

Sugi Predict / Compounds / SCHEMBL2477499

SCHEMBL2477499

SCHEMBL2477499

CC(C)(C)NCCCCCNC(C)(C)C

nearest known ligand 0.45

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ HRH4 Q9H3N8 2/20 0.45
▸ HRH3 Q9Y5N1 2/20 0.45
▸ POLB P06746 1/20 0.37
▸ CYP1A2 P05177 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ KDM1A O60341 1/20 0.32
▸ EPHX1 P07099 1/20 0.32
▸ RAB9A P51151 1/20 0.32
▸ TP53BP1 Q12888 4/20 0.32
▸ KDM4E B2RXH2 3/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ MAPK1 P28482 1/20 0.30
▸ HIF1A Q16665 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13884243 1.00 HRH4 (0.45) HRH4HRH3POLBCYP1A2CYP2C19
SCHEMBL13884273 1.00 HRH4 (0.45) HRH4HRH3POLBCYP1A2CYP2C19
SCHEMBL1276622 1.00 HRH4 (0.45) HRH4HRH3POLBCYP1A2CYP2C19
SCHEMBL13884271 1.00 HRH4 (0.45) HRH4HRH3POLBCYP1A2CYP2C19
SCHEMBL13884287 1.00 HRH4 (0.45) HRH4HRH3POLBCYP1A2CYP2C19
SCHEMBL14176497 1.00 HRH4 (0.45) HRH4HRH3POLBCYP1A2CYP2C19
SCHEMBL14176530 1.00 HRH4 (0.45) HRH4HRH3POLBCYP1A2CYP2C19
SCHEMBL7834390 0.96 HRH4 (0.43) HRH4HRH3POLBCYP1A2CYP2C19
SCHEMBL18351665 0.93 HRH4 (0.42) HRH4HRH3POLBCYP1A2CYP2C19
SCHEMBL5839106 0.89 HRH4 (0.39) HRH4HRH3POLBCYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1928786-B1 PROCESSES FOR PREPARING MTT ZEOLITES USING NITROGEN-CONTAINING ORGANIC COMPOUNDS CHEVRON USA INC (US) 2016-12-28 — — EP claimed
EP-1928786-A1 PROCESSES FOR PREPARING MTT ZEOLITES USING NITROGEN-CONTAINING ORGANIC COMPOUNDS Chevron U.S.A., Inc. (US) 2008-06-11 — — EP claimed
WO-2007027437-A1 PROCESSES FOR PREPARING MTT ZEOLITES USING NITROGEN-CONTAINING ORGANIC COMPOUNDS CHEVRON U.S.A. INC. (US) 2007-03-08 — — WO claimed
US-20240209149-A1 BIO-BASED POLYAMIDE ELASTOMER AND PREPARATION METHOD THEREFOR CATHAY BIOTECH INC. (CN) 2024-06-27 — — US disclosed
US-20240209149-A1 BIO-BASED POLYAMIDE ELASTOMER AND PREPARATION METHOD THEREFOR CATHAY BIOTECH INC. (CN) 2024-06-27 — — US disclosed
US-20180166744-A1 POLYMER NETWORK SINGLE-ION CONDUCTORS WITH FLEXIBLE LINKER THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2018-06-14 — — US disclosed
EP-2373416-B1 HIGH ACTIVITY MTT FRAMEWORK TYPE MOLECULAR SIEVES EXXONMOBIL RES & ENG CO (US) 2018-03-21 — — EP disclosed
EP-1928786-B1 PROCESSES FOR PREPARING MTT ZEOLITES USING NITROGEN-CONTAINING ORGANIC COMPOUNDS CHEVRON USA INC (US) 2016-12-28 — — EP disclosed
EP-2373416-A1 HIGH ACTIVITY MTT FRAMEWORK TYPE MOLECULAR SIEVES ExxonMobil Research and Engineering Company (US) 2011-10-12 — — EP disclosed
WO-2010074722-A1 HIGH ACTIVITY MTT FRAMEWORK TYPE MOLECULAR SIEVES EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2010-07-01 — — WO disclosed
US-20090111737-A1 Novel antibacterial agents THERAVANCE BIOPHARMA ANTIBIOTICS IP, LLC 2009-04-30 — — US disclosed
US-7384946-B2 N-{4-[2-([11-azatricyclo[6.2.1.02,7]undeca-2,4,6-trien-11-yl)-ethyl]-cyclohexyl}-2-[2-({4-[2-([11-azatricyclo[6.2.1.02,7]undeca-2,4,6-trien-11-yl)-ethyl]-cyclohexylcarbamoyl}}-methyl)-phenyl]]-acetamide; respiratory system disorders: COPD, bronchitis, asthma, pulmonary fibrosis, emphysema, rhinitis GLAXO GROUP LIMITED (GB) 2008-06-10 — — US disclosed
US-20070196859-A1 Novel antibacterial agents THERAVANCE BIOPHARMA ANTIBIOTICS IP, LLC 2007-08-23 — — US disclosed
US-20070149598-A1 M3 muscarinic acetylcholine receptor antagonists GLAXO GROUP LIMITED (GB) 2007-06-28 — — US disclosed
US-20070149598-A1 M3 muscarinic acetylcholine receptor antagonists GLAXO GROUP LIMITED (GB) 2007-06-28 — — US disclosed
US-20070134729-A1 Novel antibacterial agents THERAVANCE BIOPHARMA ANTIBIOTICS IP, LLC 2007-06-14 — — US disclosed
WO-2007027437-A1 PROCESSES FOR PREPARING MTT ZEOLITES USING NITROGEN-CONTAINING ORGANIC COMPOUNDS CHEVRON U.S.A. INC. (US) 2007-03-08 — — WO disclosed
WO-2007027437-A1 PROCESSES FOR PREPARING MTT ZEOLITES USING NITROGEN-CONTAINING ORGANIC COMPOUNDS CHEVRON U.S.A. INC. (US) 2007-03-08 — — WO disclosed
US-7157075-B1 Process for preparing MTT zeolites using nitrogen-containing organic compounds CHEVRON U.S.A. INC. (US) 2007-01-02 — — US disclosed
US-7157075-B1 Process for preparing MTT zeolites using nitrogen-containing organic compounds CHEVRON U.S.A. INC. (US) 2007-01-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070196859-A1 Novel antibacterial agents ENGASE, PEPD, PGLS HRH4 3892/4885HRH3 4322/4885POLB 1367/4885
US-20070134729-A1 Novel antibacterial agents ENGASE, PGLS, PEPD HRH4 4031/4885HRH3 4422/4885POLB 1148/4885
US-20070149598-A1 M3 muscarinic acetylcholine receptor antagonists CHRM3, CHRM2, CHRM5 HRH4 51/4885HRH3 47/4885POLB 4672/4885
US-20090111737-A1 Novel antibacterial agents ENGASE, PGLS, PEPD HRH4 4031/4885HRH3 4422/4885POLB 1148/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.